Aspen Pharmacare Holdings Ltd stock price and financial data
Prepare your investment and research the stock. Aspen Pharmacare Holdings Ltd (APNJ.J), JSE : share price and history, results and fundamentals, analysis tools and peer companies.
An investment account is required to buy shares. Demo mode uses virtual money: no order is sent to the market.
Price history
Issuer profile
Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded multinational pharmaceutical company. The Company focuses on marketing and manufacturing a range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. Its segments include Prescription, Over the counter (OTC), Injectables, Active Pharmaceutical Ingredients (API), Finished Dose Form (FDF) and Heparin. It offers sterile products in injectable form primarily administered in hospitals and also those prescribed and administered by either physicians or in a retail pharmacy environment. Its key brands include Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon and Xylocaine (Injectables). Its OTC segment includes products that do not require prescriptions and are primarily sold in the retail pharmacy and fast-moving consumer goods sectors.
Fundamentals
| Metric (ZAR, M) | 2026 2026 | 2001 2001 |
|---|---|---|
| Revenue Total Revenue | 45.02 | |
| EBITDA | 10.72 | |
| EBIT | 8.01 | |
| Net income Net Income | 5.56 | |
| Net margin | 12.35% |